Medical Devices

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2018-2025

  • QYR2795698
  • 96 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
In 2017, the global Spinal Muscular Atrophy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spinal Muscular Atrophy development in United States, Europe and China.

The key players covered in this study

Lonis Pharmaceuticals

F. Hoffmann-La Roche

AveXis

Novartis

Cytokinetics

Ionis Pharmaceuticals

...

Market segment by Type, the product can be split into

Early Stage Candidates

Late Stage Candidates

Market segment by Application, split into

Hospital

Clinic

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players.

To present the Spinal Muscular Atrophy development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Spinal Muscular Atrophy are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type (2013-2025)

1.4.2 Early Stage Candidates

1.4.3 Late Stage Candidates

1.5 Market by Application

1.5.1 Global Spinal Muscular Atrophy Market Share by Application (2013-2025)

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Spinal Muscular Atrophy Market Size

2.2 Spinal Muscular Atrophy Growth Trends by Regions

2.2.1 Spinal Muscular Atrophy Market Size by Regions (2013-2025)

2.2.2 Spinal Muscular Atrophy Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Spinal Muscular Atrophy Market Size by Manufacturers

3.1.1 Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018)

3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI)

3.2 Spinal Muscular Atrophy Key Players Head office and Area Served

3.3 Key Players Spinal Muscular Atrophy Product/Solution/Service

3.4 Date of Enter into Spinal Muscular Atrophy Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)

4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)

5 United States

5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)

5.2 Spinal Muscular Atrophy Key Players in United States

5.3 United States Spinal Muscular Atrophy Market Size by Type

5.4 United States Spinal Muscular Atrophy Market Size by Application

6 Europe

6.1 Europe Spinal Muscular Atrophy Market Size (2013-2018)

6.2 Spinal Muscular Atrophy Key Players in Europe

6.3 Europe Spinal Muscular Atrophy Market Size by Type

6.4 Europe Spinal Muscular Atrophy Market Size by Application

7 China

7.1 China Spinal Muscular Atrophy Market Size (2013-2018)

7.2 Spinal Muscular Atrophy Key Players in China

7.3 China Spinal Muscular Atrophy Market Size by Type

7.4 China Spinal Muscular Atrophy Market Size by Application

8 Japan

8.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)

8.2 Spinal Muscular Atrophy Key Players in Japan

8.3 Japan Spinal Muscular Atrophy Market Size by Type

8.4 Japan Spinal Muscular Atrophy Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)

9.2 Spinal Muscular Atrophy Key Players in Southeast Asia

9.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type

9.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application

10 India

10.1 India Spinal Muscular Atrophy Market Size (2013-2018)

10.2 Spinal Muscular Atrophy Key Players in India

10.3 India Spinal Muscular Atrophy Market Size by Type

10.4 India Spinal Muscular Atrophy Market Size by Application

11 Central & South America

11.1 Central & South America Spinal Muscular Atrophy Market Size (2013-2018)

11.2 Spinal Muscular Atrophy Key Players in Central & South America

11.3 Central & South America Spinal Muscular Atrophy Market Size by Type

11.4 Central & South America Spinal Muscular Atrophy Market Size by Application

12 International Players Profiles

12.1 Lonis Pharmaceuticals

12.1.1 Lonis Pharmaceuticals Company Details

12.1.2 Company Description and Business Overview

12.1.3 Spinal Muscular Atrophy Introduction

12.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.1.5 Lonis Pharmaceuticals Recent Development

12.2 F. Hoffmann-La Roche

12.2.1 F. Hoffmann-La Roche Company Details

12.2.2 Company Description and Business Overview

12.2.3 Spinal Muscular Atrophy Introduction

12.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.2.5 F. Hoffmann-La Roche Recent Development

12.3 AveXis

12.3.1 AveXis Company Details

12.3.2 Company Description and Business Overview

12.3.3 Spinal Muscular Atrophy Introduction

12.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.3.5 AveXis Recent Development

12.4 Novartis

12.4.1 Novartis Company Details

12.4.2 Company Description and Business Overview

12.4.3 Spinal Muscular Atrophy Introduction

12.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.4.5 Novartis Recent Development

12.5 Cytokinetics

12.5.1 Cytokinetics Company Details

12.5.2 Company Description and Business Overview

12.5.3 Spinal Muscular Atrophy Introduction

12.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.5.5 Cytokinetics Recent Development

12.6 Ionis Pharmaceuticals

12.6.1 Ionis Pharmaceuticals Company Details

12.6.2 Company Description and Business Overview

12.6.3 Spinal Muscular Atrophy Introduction

12.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)

12.6.5 Ionis Pharmaceuticals Recent Development

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst\'s Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Spinal Muscular Atrophy Key Market Segments

Table Key Players Spinal Muscular Atrophy Covered

Table Global Spinal Muscular Atrophy Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Spinal Muscular Atrophy Market Size Market Share by Type 2013-2025

Figure Early Stage Candidates Figures

Table Key Players of Early Stage Candidates

Figure Late Stage Candidates Figures

Table Key Players of Late Stage Candidates

Table Global Spinal Muscular Atrophy Market Size Growth by Application 2013-2025 (Million US$)

Figure Hospital Case Studies

Figure Clinic Case Studies

Figure Others Case Studies

Figure Spinal Muscular Atrophy Report Years Considered

Table Global Spinal Muscular Atrophy Market Size 2013-2025 (Million US$)

Figure Global Spinal Muscular Atrophy Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2025 (Million US$)

Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2018 (Million US$)

Table Global Spinal Muscular Atrophy Market Share by Regions 2013-2018

Figure Global Spinal Muscular Atrophy Market Share by Regions 2013-2018

Figure Global Spinal Muscular Atrophy Market Share by Regions 2018

Table Market Top Trends

Table Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Spinal Muscular Atrophy Market Share by Manufacturers (2013-2018)

Figure Global Spinal Muscular Atrophy Market Share by Manufacturers in 2018

Table Global Spinal Muscular Atrophy Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Spinal Muscular Atrophy Product/Solution/Service

Table Date of Enter into Spinal Muscular Atrophy Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table Global Spinal Muscular Atrophy Market Size Share by Type (2013-2018)

Figure Global Spinal Muscular Atrophy Market Size Market Share by Type (2013-2018)

Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table Global Spinal Muscular Atrophy Market Size Share by Application (2013-2018)

Figure Global Spinal Muscular Atrophy Market Size Market Share by Application (2013-2018)

Figure Global Spinal Muscular Atrophy Revenue Market Share by Application in 2017

Figure United States Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table United States Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table United States Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table United States Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table United States Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table United States Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure Europe Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table Europe Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table Europe Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table Europe Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table Europe Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table Europe Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table Europe Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure China Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table China Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table China Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table China Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table China Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table China Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table China Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure Japan Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table Japan Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table Japan Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table Japan Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table Japan Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table Japan Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure Southeast Asia Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table Southeast Asia Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure India Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table India Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table India Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table India Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table India Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table India Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table India Spinal Muscular Atrophy Market Share by Application (2013-2018)

Figure Central & South America Spinal Muscular Atrophy Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Spinal Muscular Atrophy Market Share (2017-2018)

Table Central & South America Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$)

Table Central & South America Spinal Muscular Atrophy Market Share by Type (2013-2018)

Table Central & South America Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$)

Table Central & South America Spinal Muscular Atrophy Market Share by Application (2013-2018)

Table Lonis Pharmaceuticals Company Details

Table Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) (Million US$)

Figure Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table Lonis Pharmaceuticals Recent Development

Table F. Hoffmann-La Roche Company Details

Table F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)

Figure F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table F. Hoffmann-La Roche Recent Development

Table AveXis Company Details

Table AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)

Figure AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table AveXis Recent Development

Table Novartis Company Details

Table Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)

Figure Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table Novartis Recent Development

Table Cytokinetics Company Details

Table Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)

Figure Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table Cytokinetics Recent Development

Table Ionis Pharmaceuticals Company Details

Table Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$)

Figure Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018)

Table Ionis Pharmaceuticals Recent Development

Table Global Spinal Muscular Atrophy Market Size by Regions (Million US$) 2018-2025

Figure Global Spinal Muscular Atrophy Market Size Share by Regions (2018-2025)

Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025

Figure United States Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure Europe Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure China Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure Japan Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure India Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD)

Table Global Spinal Muscular Atrophy Market Size by Product (2018-2025) (Million US$)

Figure Global Spinal Muscular Atrophy Market Size by Product (2018-2025)

Figure Global Spinal Muscular Atrophy Market Size by Product in 2025

Table Global Spinal Muscular Atrophy Market Size by Application (2018-2025) (Million US$)

Figure Global Spinal Muscular Atrophy Market Size by Application (2018-2025)

Figure Global Spinal Muscular Atrophy Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370